129 related articles for article (PubMed ID: 7323033)
1. [Comparative study of the estrogenic activity of modified estrogens based on data of competitive binding analysis and biological assay].
Pokrovskaia EV; Ivanenko TI
Probl Endokrinol (Mosk); 1981; 27(6):66-70. PubMed ID: 7323033
[TBL] [Abstract][Full Text] [Related]
2. Effects of estrogens P-1496 and P-1560 on the binding of estradiol with rat uterine estrogen receptors.
Di Carlo F; Conti G; Reboani C; Racca S
Farmaco Sci; 1980 May; 35(5):425-9. PubMed ID: 7450040
[TBL] [Abstract][Full Text] [Related]
3. [Comparative analysis of the interaction of various estrogens with the estrogen-receptor system of the uterus].
Fanchenko ND; Alekseeva ML; Minina LS; Novikov EA; Khel'mun DK
Biokhimiia; 1985 Nov; 50(11):1853-8. PubMed ID: 4063405
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of B-, C-, and D-ring-substituted estradiol carboxylic acid esters as locally active estrogens.
Labaree DC; Zhang JX; Harris HA; O'Connor C; Reynolds TY; Hochberg RB
J Med Chem; 2003 May; 46(10):1886-904. PubMed ID: 12723952
[TBL] [Abstract][Full Text] [Related]
5. [Properties of alkylating derivatives of estrogens].
Morozova TM; Merkulova TI; Martynov V; Iaguzhinskaia VP; Shkodinskaia EN
Eksp Onkol; 1984; 6(2):50-4. PubMed ID: 6510335
[TBL] [Abstract][Full Text] [Related]
6. Further report on the endocrinological profile of two synthetic estrogens with antifertility properties, STS 456 and STS 593.
Koch M; Ivanenko TI; Kurischko AJ; Pokrovskaya EV; Fedotov VP; Freund H; Oettel M
Exp Clin Endocrinol; 1985 Dec; 86(3):257-65. PubMed ID: 4092738
[TBL] [Abstract][Full Text] [Related]
7. Two binding sites for estradiol in rat uterine nuclei: relationship to uterotropic response.
Markaverich BM; Clark JH
Endocrinology; 1979 Dec; 105(6):1458-62. PubMed ID: 574077
[No Abstract] [Full Text] [Related]
8. Differential stimulation by 17 beta-estradiol and synthetic estrogens of progesterone-receptor and of translocation of estrogen-receptor in rat pituitary and uterus.
Leibl H; Spona J
Endocrinology; 1982 Jan; 110(1):265-71. PubMed ID: 7053987
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships of 9 beta-estrogens.
Gabbard RB; Segaloff A
Steroids; 1983 Nov; 42(5):555-63. PubMed ID: 6680929
[TBL] [Abstract][Full Text] [Related]
10. Estrogen derivatives for the external localization of estrogen-dependent malignancy.
Komai T; Eckelman WC; Johnsonbaugh RE; Mazaitis A; Kubota H; Reba RC
J Nucl Med; 1977 Apr; 18(4):360-6. PubMed ID: 845665
[TBL] [Abstract][Full Text] [Related]
11. Estrogenic properties of 3,9-dihydroxy-7,12-dimethylbenz[a]anthracene in rats.
Morreal CE; Schneider SL; Sinha DK; Bronstein RE
J Natl Cancer Inst; 1979 Jun; 62(6):1585-8. PubMed ID: 108445
[TBL] [Abstract][Full Text] [Related]
12. Interaction of ring B unsaturated estrogens with estrogen receptors of human endometrium and rat uterus.
Bhavnani BR; Woolever CA
Steroids; 1991 Apr; 56(4):201-10. PubMed ID: 1871786
[TBL] [Abstract][Full Text] [Related]
13. Estrogen action in the mouse uterus: characterization of the cytosol and nuclear receptor systems.
Korach KS
Endocrinology; 1979 May; 104(5):1324-32. PubMed ID: 436778
[No Abstract] [Full Text] [Related]
14. [Possible heterogeneity of cytoplasmic estrogen receptors].
Alekseeva ML; Minina LS; Novikov EA; Shchedrina RN; Fanchenko ND
Vopr Med Khim; 1984; 30(5):62-5. PubMed ID: 6528522
[TBL] [Abstract][Full Text] [Related]
15. Properties of the estrogen receptor in the human oviduct and its interaction with ethinylestradiol and mestranol in vitro.
Muechler EK; Kohler D
J Clin Endocrinol Metab; 1980 Nov; 51(5):962-7. PubMed ID: 7419693
[TBL] [Abstract][Full Text] [Related]
16. Estrogenic properties of 3,9-dihydroxybenz[a]anthracene, a potential metabolite of benz[a]anthracene.
Schneider SL; Alks V; Morreal CE; Sinha DK; Dao TL
J Natl Cancer Inst; 1976 Dec; 57(6):1351-4. PubMed ID: 826653
[TBL] [Abstract][Full Text] [Related]
17. Nuclear translocation of estrogen-receptor complex and stimulation of RNA synthesis by estrogens of different biological potencies in the female rat pituitary.
Spona J; Leibl H; Bieglmayer C
Biochim Biophys Acta; 1980 Apr; 607(2):189-200. PubMed ID: 6154480
[TBL] [Abstract][Full Text] [Related]
18. CDRI-85/287: studies on competition to estrogen binding sites in the immature rat uterus.
Sreenivasulu S; Dwivedi A; Singh MM; Setty BS; Kamboj VP
Indian J Exp Biol; 1992 Dec; 30(12):1115-7. PubMed ID: 1294475
[TBL] [Abstract][Full Text] [Related]
19. Selenium labeling in nuclear medicine. 2. D ring substituted estrogens.
Sadek SA; Kessler WV; Shaw SM; Anderson JN; Wolf GC
J Med Chem; 1982 Dec; 25(12):1488-92. PubMed ID: 6891404
[No Abstract] [Full Text] [Related]
20. [The estrogenic activities of 2-[3-estrone-N-ethyl-piperazine-methyl]tetracycline(XW630)--a new compound with anti-osteoporosis activity].
Mo Z; Jiao X; Su H; Zheng H; Weng L
Yao Xue Xue Bao; 1998 Sep; 33(9):645-9. PubMed ID: 12016866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
